Evidence map›Paper›PMID 24935993›Full record

ArticlePediatrics2014

Effectiveness of anti-TNFα for Crohn disease: research in a pediatric learning health system.

Christopher B Forrest, Wallace V Crandall, L Charles Bailey, Peixin Zhang, Marshall M Joffe, Richard B Colletti, Jeremy Adler, Howard I Baron, James Berman, Fernando del Rosario and 12 more

Registry-linked trialAbstract read
In one paragraph

Article in Pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05689892 (Impact of a Shared Decision Making Intervention in Paediatric Inflammatory Bowel Disease Therapeutic Decision-making), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05689892 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Impact of a Shared Decision Making Intervention in Paediatric Inflammatory Bowel Disease Therapeutic Decision-making

TypeinterventionalSponsorLondon Health Sciences CentreRan2024 to 2025Enrolled150ConditionsInflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis, IBDArmsDecision Coach Sessions
3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Observational
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Robust-ODAL: Learning from heterogeneous health systems without sharing patient-level data.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2020
    Article
  11. Shared decision making in IBD: A novel approach to trial consent and timing.Contemporary clinical trials communications · 2019
    Article
  12. Shared Decision Making About Starting Anti-TNFs: A Pediatric Perspective.Journal of pediatric gastroenterology and nutrition · 2019
    Article
  13. Review
  14. Article
  15. Article
  16. Learning Health Systems as Facilitators of Precision Medicine.Clinical pharmacology and therapeutics · 2017
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Christopher B ForrestDepartment of Pediatrics, andLeonard Davis Institute of Health Economics, and forrestc@email.chop.edu.
Wallace V CrandallDepartment of Pediatrics, The Ohio State University College of Medicine, Nationwide Children's Hospital, Columbus, Ohio;
L Charles BaileyDepartment of Pediatrics, andCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania;
Peixin ZhangDepartment of Pediatrics, and.
Marshall M JoffeCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania;
Richard B CollettiDepartment of Pediatrics, The University of Vermont College of Medicine, Burlington, Vermont;
Jeremy AdlerDepartment of Pediatrics and Communicable Diseases, Division of Pediatric Gastroenterology, University of Michigan, Ann Arbor, Michigan;
Howard I BaronDepartment of Pediatrics, University of Nevada School of Medicine, Pediatric Gastroenterology and Nutrition Associates, Las Vegas, Nevada;
James BermanAdvocate Children's Hospital, UIC College of Medicine, Loyola University School of Medicine, Chicago, Illinois;
Fernando del RosarioDepartment of Pediatrics, Division of Pediatric Gastroenterology Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware;
Andrew B GrossmanDivision of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania;
Edward J HoffenbergDepartment of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado;
Esther J IsraelDepartment of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, Boston, Massachusetts;
Sandra C KimDepartment of Pediatrics, The Ohio State University College of Medicine, Nationwide Children's Hospital, Columbus, Ohio;
Jenifer R LightdaleDepartment of Medicine, Boston Children's Hospital, Boston, Massachusetts;
Peter A MargolisDepartment of Pediatrics, James M. Anderson Center for Health Systems Excellence, and.
Keith MarsoloDivision of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio;
Devendra I MehtaDepartment of Pediatrics, Arnold Palmer Hospital for Children, Florida State University, Orlando, Florida;
David E MilovDepartment of Pediatrics, Nemour's Children's Hospital, Orlando, Florida;
Ashish S PatelDepartment of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, Texas;Department of Pediatrics, Children's Medical Center, Dallas, Texas;
Jeanne TungDepartment of Pediatric and Adolescent Medicine, Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota; and.
Michael D KappelmanDepartment of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Funding

Building Modular Pediatric Chronic Disease Registries for QI and CE ResearchR01HS020024 · AHRQ · CINCINNATI CHILDRENS HOSP MED CTR · PI HUTTON, JOHN J · 2010 to 2010
$11.7M
Exposure to antibiotics during infancy and subsequent risk of Crohn's disease: aK08DK088957 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAPPELMAN, MICHAEL D · 2011 to 2013
$457k
AHRQ HHS R01 HS020024NIDDK NIH HHS K08 DK088957
6 · The paper itself

Abstract

objectivesImproveCareNow (ICN) is the largest pediatric learning health system in the nation and started as a quality improvement collaborative. To test the feasibility and validity of using ICN data for clinical research, we evaluated the effectiveness of anti-tumor necrosis factor-α (anti-TNFα) agents in the management of pediatric Crohn disease (CD).

methodsData were collected in 35 pediatric gastroenterology practices (April 2007 to March 2012) and analyzed as a sequence of nonrandomized trials. Patients who had moderate to severe CD were classified as initiators or non-initiators of anti-TNFα therapy. Among 4130 patients who had pediatric CD, 603 were new users and 1211 were receiving anti-TNFα therapy on entry into ICN.

resultsDuring a 26-week follow-up period, rate ratios obtained from Cox proportional hazards models, adjusting for patient and disease characteristics and concurrent medications, were 1.53 (95% confidence interval [CI], 1.20-1.96) for clinical remission and 1.74 (95% CI, 1.33-2.29) for corticosteroid-free remission. The rate ratio for corticosteroid-free remission was comparable to the estimate produced by the adult SONIC study, which was a randomized controlled trial on the efficacy of anti-TNFα therapy. The number needed to treat was 5.2 (95% CI, 3.4-11.1) for clinical remission and 5.0 (95% CI, 3.4-10.0) for corticosteroid-free remission.

conclusionsIn routine pediatric gastroenterology practice settings, anti-TNFα therapy was effective at achieving clinical and corticosteroid-free remission for patients who had Crohn disease. Using data from the ICN learning health system for the purpose of observational research is feasible and produces valuable new knowledge.

Indexed as

AdolescentBiomedical ResearchControlled Clinical Trials as TopicCrohn DiseaseFeasibility StudiesFemaleHumansMalePediatricsTumor Necrosis Factor-alphaTumor Necrosis Factor-alphaanti-tumor necrosis factor-αchildcomparative effectiveness researchCrohn disease

Identifiers

PMID24935993
PMCPMC4531278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.